Published in Toxicol In Vitro on August 01, 1994
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29
Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet (1979) 6.10
West Nile virus infection in birds and mosquitoes, New York State, 2000. Emerg Infect Dis (2001) 4.27
Delta-F508 cystic fibrosis mutation is not linked to intussusception: implications for rotavirus vaccine. J Paediatr Child Health (2003) 3.59
Improved survival after orthotopic liver grafting. Br Med J (Clin Res Ed) (1981) 3.09
Cyclosporin A in cadaveric organ transplantation. Br Med J (Clin Res Ed) (1981) 2.67
Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A. Lancet (1978) 2.57
Rapamycin for immunosuppression in organ allografting. Lancet (1989) 2.51
West Nile virus in overwintering Culex mosquitoes, New York City, 2000. Emerg Infect Dis (2001) 2.48
Cyclosporine: five years' experience in cadaveric renal transplantation. N Engl J Med (1984) 2.10
West Nile virus isolates from mosquitoes in New York and New Jersey, 1999. Emerg Infect Dis (2001) 2.05
Cyclosporin A: preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants. Transplant Proc (1979) 1.94
The generation of transgenic pigs as potential organ donors for humans. Nat Med (1995) 1.86
Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation (2000) 1.83
A high-resolution NMR probe in which the coil and preamplifier are cooled with liquid helium. 1984. J Magn Reson (2011) 1.75
Cyclosporin A: an immunosuppressive agent preferentially active against proliferating T cells. Transplantation (1979) 1.73
Stomach as source of bacteria colonising respiratory tract during artificial ventilation. Lancet (1978) 1.69
Human babesiosis in New York State: an epidemiological description of 136 cases. Clin Infect Dis (1992) 1.61
Umbilicoplasty: the construction of a new umbilicus and correction of umbilical stenosis without external scars. Plast Reconstr Surg (1996) 1.51
Sonographic findings in perforation of the gallbladder. AJR Am J Roentgenol (1982) 1.51
Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy. J Infect Dis (2000) 1.43
Implementation of a proficiency testing program for Lyme disease in New York State. Arch Pathol Lab Med (1994) 1.42
Trends in sexually transmitted infections (other than HIV) in older people: analysis of data from an enhanced surveillance system. Sex Transm Infect (2008) 1.41
Surveillance of sexually transmitted infections in the West Midlands using anonymised individual patient datasets from genitourinary medicine clinics. Commun Dis Public Health (2004) 1.40
Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line. Br J Cancer (1987) 1.40
Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J Exp Med (1992) 1.38
Surgical treatment of cardiac pheochromocytomas. J Thorac Cardiovasc Surg (1985) 1.34
West Nile virus: a case study in how NY State Health Information infrastructure facilitates preparation and response to disease outbreaks. J Public Health Manag Pract (2001) 1.27
Mode of action of cyclosporin A: a new immunosuppressive agent. Transplant Proc (1979) 1.26
Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer. Br J Cancer (2000) 1.23
FK-506 in experimental renal allografts. Transplant Proc (1987) 1.23
Structure of the bacteriophage lambda Ser/Thr protein phosphatase with sulfate ion bound in two coordination modes. Biochemistry (2000) 1.20
Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation (2000) 1.19
Occupational risk of Lyme disease in endemic areas of New York State. Ann N Y Acad Sci (1988) 1.18
Cyclosporin-A in clinical organ grafting. Transplant Proc (1981) 1.16
Lyme disease in New York State: spatial pattern at a regional scale. Am J Trop Med Hyg (2001) 1.14
Antiretroviral drug concentrations in semen of HIV-infected men: differential penetration of indinavir, ritonavir and saquinavir. J Antimicrob Chemother (2001) 1.14
Concentrations of nevirapine, lamivudine and stavudine in semen of HIV-1-infected men. AIDS (2000) 1.14
Clinical pharmacology and safety evaluation of Timentin. Am J Med (1985) 1.12
Serosurvey for human babesiosis in New York. J Infect Dis (1980) 1.10
Heterotopic heart transplantation in the rat receiving FK-506. Transplant Proc (1987) 1.10
Newborn screening for cystic fibrosis in Victoria: 10 years' experience (1989-1998). Med J Aust (2000) 1.08
Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation (2000) 1.07
Diagnosis of cystic hydatid disease: role of aspiration cytology. Lancet (1988) 1.07
Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. Diabetes (1998) 1.07
Comparison of adipose tissue changes following administration of rosiglitazone in the dog and rat. Diabetes Obes Metab (2001) 1.06
Three-month survival of HDAFF transgenic pig hearts transplanted into primates. Transplant Proc (1999) 1.06
Poor penetration of the male genital tract by HIV-1 protease inhibitors. AIDS (1999) 1.05
Seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the northeast United States. Am J Med (1999) 1.04
CT-SPECT fusion plus conjugate views for determining dosimetry in iodine-131-monoclonal antibody therapy of lymphoma patients. J Nucl Med (1994) 1.03
Physiological aspects of pig-to-primate renal xenotransplantation. Kidney Int (2001) 1.03
Reactivity of fluoride dentifrices with artificial caries. I. Effects on early lesions: F uptake, surface hardening and remineralization. Caries Res (1987) 1.02
The use of Cyclosporin A immunosuppression in organ grafting. Immunol Rev (1982) 1.02
Prolonged survival of hamster to rat heart xenografts with cyclophosphamide therapy. Transplant Proc (1992) 1.01
Characterization of pigs transgenic for human decay-accelerating factor. Transplantation (1997) 1.01
Overexpression of cardiac I-kappaBalpha prevents endotoxin-induced myocardial dysfunction. Am J Physiol Heart Circ Physiol (2001) 1.01
Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation (1998) 0.99
Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat. Diabetes Obes Metab (2000) 0.99
A method to study sustained antimicrobial activity of rinse and dentifrice components on biofilm viability in vivo. J Clin Periodontol (2006) 0.98
Evidence that long-term survival of concordant xenografts is achieved by inhibition of antispecies antibody production. Transplantation (1992) 0.98
A longitudinal microhardness analysis of fluoride dentifrice effects on lesion progression in vitro. Caries Res (1987) 0.97
Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation (1997) 0.96
Early renal allograft rejection episodes are less aggressive with cyclosporin-A immunosuppression. Transplant Proc (1983) 0.96
Penetration of efavirenz into the male genital tract: drug concentrations and antiviral activity in semen and blood of HIV-1-infected men. AIDS (2001) 0.96
Effect of oral vitamin E (alpha-tocopherol) supplementation on vascular endothelial function in Type 2 diabetes mellitus. Diabet Med (1999) 0.95
Cyclosporin A. Clinical pharmacology and therapeutic potential. Drugs (1982) 0.94
Genetic screening of newborn in Australia. Results for 1981. Med J Aust (1983) 0.94
The immune status of transplant recipients immunosuppressed with cyclosporin-A. Transplant Proc (1981) 0.94
Both concordant and discordant heart xenografts are rejected by athymic (nude) rats with the same tempo as in T cell competent animals. Transplant Proc (1991) 0.94
An analysis of concordant xenograft rejection in the nude rat model. Transplant Proc (1990) 0.94
Thyroid function in very preterm infants. Early Hum Dev (1988) 0.94
Effect of potent urease inhibitor, fluorofamide, on Helicobacter sp. in vivo and in vitro. Dig Dis Sci (1998) 0.94
Adrenal radiology: distinguishing benign from malignant adrenal masses. AJR Am J Roentgenol (1996) 0.94
Consistent prolonged "concordant" survival of hamster-to-rat cardiac xenografts by inhibition of anti-species antibodies with methotrexate. Transplant Proc (1993) 0.93
The use of cyclosporin A in clinical organ grafting. Ann Surg (1982) 0.93
Regulation of the complement cascade by soluble complement receptor type 1. Protective effect in experimental liver ischemia and reperfusion. Transplantation (1995) 0.93
The location of middle mediastinal pheochromocytomas. J Thorac Cardiovasc Surg (1984) 0.93
Evidence for multiple foci of eastern equine encephalitis virus (Togaviridae:Alphavirus) in central New York State. J Med Entomol (1996) 0.92
Potential benefit of inhibitors of advanced glycation end products in the progression of type II diabetes: a study with aminoguanidine in C57/BLKsJ diabetic mice. Metabolism (1998) 0.92
Babesiosis in Long Island. Host-parasite relationships of rodent- and human-derived Babesia microti isolates in hamsters. Am J Trop Med Hyg (1978) 0.92
Antioxidant vitamin therapy alters burn trauma-mediated cardiac NF-kappaB activation and cardiomyocyte cytokine secretion. J Trauma (2001) 0.91
New distribution records of Amblyomma americanum (L.) (Acari: Ixodidae) in New York State. J Vector Ecol (1997) 0.91
The effect of long-term cyclosporin A on renal function. Lancet (1981) 0.91
Progress in xenotransplantation. Clin Nephrol (2000) 0.91
Role of p38 mitogen-activated protein kinase in cardiac myocyte secretion of the inflammatory cytokine TNF-alpha. Am J Physiol Heart Circ Physiol (2001) 0.91
The effects of multivitamin supplementation on mood and general well-being in healthy young adults. A laboratory and at-home mobile phone assessment. Appetite (2013) 0.90
Cyclosporin G: immunosuppressive effect in dogs with renal allografts. Lancet (1985) 0.90
Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock. Am J Physiol (1994) 0.90
Changing patterns in the incidence of Rocky Mountain Spotted Fever on Long Island (1971-1976). Am J Epidemiol (1977) 0.90
Effect of an anticalculus dentifrice on lesion progression under pH cycling conditions in vitro. Caries Res (1988) 0.90
Nanoimprinted optical fibres: Biotemplated nanostructures for SERS sensing. Biosens Bioelectron (2008) 0.90
Life supporting function for over one month of a transgenic porcine heart in a baboon. J Heart Lung Transplant (2000) 0.89
A regional technique for the study of sensitivity to curare in human muscle. J Neurol Neurosurg Psychiatry (1975) 0.89
Kinetics of unresponsiveness induced by a short course of cyclosporin A. Transplantation (1982) 0.89
Two crystal structures of the cytoplasmic molybdate-binding protein ModG suggest a novel cooperative binding mechanism and provide insights into ligand-binding specificity. J Mol Biol (2001) 0.89
Renal and segmental pancreatic grafting with draining of exocrine secretion and initial continuous intravenous cyclosporin A in a patient with insulin-dependent diabetes and renal failure. Br Med J (Clin Res Ed) (1982) 0.89
Naturally-ccurring Tyzzer's disease in the gerbil. Vet Rec (1969) 0.89
The relationship of the histocompatibility locus in the pig to allograft survival. Transplant Proc (1973) 0.89
Cyclosporine and ketoconazole. Transplantation (1984) 0.88
The impact of newborn screening on cystic fibrosis testing in Victoria, Australia. J Med Genet (1995) 0.88